{{Rsnum
|rsid=2055011
|Gene=CHODL
|Chromosome=21
|position=18109036
|Orientation=minus
|GMAF=0.2461
|Gene_s=CHODL
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.2 | 33.9 | 62.9
| HCB | 4.9 | 34.1 | 61.0
| JPT | 2.3 | 22.7 | 75.0
| YRI | 35.5 | 48.4 | 16.1
| ASW | 0.0 | 0.0 | 0.0
| CHB | 4.9 | 34.1 | 61.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23648065
  |Trait=Adverse response to chemotherapy (neutropenia/leucopenia) (all antimetabolite drugs)
  |Title=Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan.
  |RiskAllele=C
  |Pval=9E-6
  |OR=1.35
  |ORtxt=[1.075-1.686]
  }}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}